Pfizer is testing a pill that, if successful, could become first-ever home cure for COVID-19

Classed as a 'protease inhibitor', it has been formulated to attack the "spine" of the SARS-CoV-2 virus and stop it replicating in our nose, throats and lungs

The antiviral pill was developed from scratch during the current pandemic, Dafydd Owen, director of medicinal chemistry at Pfizer, told a private symposium of the Division of Medicinal Chemistry last month...

Classed as a 'protease inhibitor', it has been formulated to attack the "spine" of the SARS-CoV-2 virus and stop it replicating in our nose, throats and lungs

The antiviral pill was developed from scratch during the current pandemic, Dafydd Owen, director of medicinal chemistry at Pfizer, told a private symposium of the Division of Medicinal Chemistry last month...